456 related articles for article (PubMed ID: 25977897)
1. Off-label use of cancer therapies in women diagnosed with breast cancer in the United States.
Hamel S; McNair DS; Birkett NJ; Mattison DR; Krantis A; Krewski D
Springerplus; 2015; 4():209. PubMed ID: 25977897
[TBL] [Abstract][Full Text] [Related]
2. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
Drugs R D; 2005; 6(3):178-85. PubMed ID: 15869322
[TBL] [Abstract][Full Text] [Related]
3. On-label and off-label prescribing patterns of erythropoiesis-stimulating agents in inpatient hospital settings in the US during the period of major regulatory changes.
Seetasith A; Holdford D; Shah A; Patterson J
Res Social Adm Pharm; 2017; 13(4):778-788. PubMed ID: 27595426
[TBL] [Abstract][Full Text] [Related]
4. Off-label prescribing patterns of antidepressants in children and adolescents.
Lee E; Teschemaker AR; Johann-Liang R; Bazemore G; Yoon M; Shim KS; Daniel M; Pittman J; Wutoh AK
Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):137-44. PubMed ID: 21538674
[TBL] [Abstract][Full Text] [Related]
5. Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.
Wong J; Motulsky A; Abrahamowicz M; Eguale T; Buckeridge DL; Tamblyn R
BMJ; 2017 Feb; 356():j603. PubMed ID: 28228380
[No Abstract] [Full Text] [Related]
6. Systematic review: reliability of compendia methods for off-label oncology indications.
Abernethy AP; Raman G; Balk EM; Hammond JM; Orlando LA; Wheeler JL; Lau J; McCrory DC
Ann Intern Med; 2009 Mar; 150(5):336-43. PubMed ID: 19221366
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
8. Off-label use of oral fluoroquinolone antibiotics in outpatient settings in the United States, 2006 to 2012.
Almalki ZS; Alahmari AK; Guo JJ; Cavanaugh TM
Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1042-51. PubMed ID: 27133913
[TBL] [Abstract][Full Text] [Related]
9. Patterns of Off-Label Prescribing in the Pediatric Intensive Care Unit and Prioritizing Future Research.
Czaja AS; Reiter PD; Schultz ML; Valuck RJ
J Pediatr Pharmacol Ther; 2015; 20(3):186-96. PubMed ID: 26170770
[TBL] [Abstract][Full Text] [Related]
10. Off-label antidepressant use in children and adolescents compared with young adults: extent and level of evidence.
Czaja AS; Valuck R
Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):997-1004. PubMed ID: 22760843
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the Appropriateness of Off-Label Antipsychotic Use for Mental Health Indications in a Veteran Population.
Painter JT; Owen R; Henderson KL; Bauer MS; Mittal D; Hudson TJ
Pharmacotherapy; 2017 Apr; 37(4):438-446. PubMed ID: 28164355
[TBL] [Abstract][Full Text] [Related]
12. Clinical setting influences off-label and unlicensed prescribing in a paediatric teaching hospital.
Czarniak P; Bint L; Favié L; Parsons R; Hughes J; Sunderland B
PLoS One; 2015; 10(3):e0120630. PubMed ID: 25756896
[TBL] [Abstract][Full Text] [Related]
13. An epidemiological investigation of off-label anticonvulsant drug use in the Georgia Medicaid population.
Chen H; Deshpande AD; Jiang R; Martin BC
Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):629-38. PubMed ID: 15597329
[TBL] [Abstract][Full Text] [Related]
14. Off-label prescribing to children in the United States outpatient setting.
Bazzano AT; Mangione-Smith R; Schonlau M; Suttorp MJ; Brook RH
Acad Pediatr; 2009; 9(2):81-8. PubMed ID: 19329098
[TBL] [Abstract][Full Text] [Related]
15. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
16. Off-label drug use in human immunodeficiency virus disease.
Brosgart CL; Mitchell T; Charlebois E; Coleman R; Mehalko S; Young J; Abrams DI
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May; 12(1):56-62. PubMed ID: 8624761
[TBL] [Abstract][Full Text] [Related]
17. The Off-Label Use of Antineoplastics in Oncology Is Limited But Has Notable Scientific Support in a University Hospital Setting.
Herrero Fernandez M; Molina Villaverde R; Arroyo Yustos M; Navarro Expósito F; Lopez Gonzalez JL; Luque Infantes MR; Alvarez-Mon Soto M
Front Pharmacol; 2019; 10():1210. PubMed ID: 31708769
[No Abstract] [Full Text] [Related]
18. Drug, patient, and physician characteristics associated with off-label prescribing in primary care.
Eguale T; Buckeridge DL; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
Arch Intern Med; 2012 May; 172(10):781-8. PubMed ID: 22507695
[TBL] [Abstract][Full Text] [Related]
19. Off-label Medication Prescribing Patterns in Pediatrics: An Update.
Yackey K; Stukus K; Cohen D; Kline D; Zhao S; Stanley R
Hosp Pediatr; 2019 Mar; 9(3):186-193. PubMed ID: 30745323
[TBL] [Abstract][Full Text] [Related]
20. Off-label prescribing in oncology.
Poole SG; Dooley MJ
Support Care Cancer; 2004 May; 12(5):302-5. PubMed ID: 14986075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
